BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 9235976)

  • 1. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of hepatitis C virus NS3 proteinase activity by association with NS4A-specific synthetic peptides: identification of sequence and critical residues of NS4A for the cofactor activity.
    Butkiewicz NJ; Wendel M; Zhang R; Jubin R; Pichardo J; Smith EB; Hart AM; Ingram R; Durkin J; Mui PW; Murray MG; Ramanathan L; Dasmahapatra B
    Virology; 1996 Nov; 225(2):328-38. PubMed ID: 8918919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS3 serine protease of bovine viral diarrhea virus: characterization of active site residues, NS4A cofactor domain, and protease-cofactor interactions.
    Tautz N; Kaiser A; Thiel HJ
    Virology; 2000 Aug; 273(2):351-63. PubMed ID: 10915606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An uniquely purified HCV NS3 protease and NS4A(21-34) peptide form a highly active serine protease complex in peptide hydrolysis.
    Sardana VV; Blue JT; Zugay-Murphy J; Sardana MK; Kuo LC
    Protein Expr Purif; 1999 Aug; 16(3):440-7. PubMed ID: 10425166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form.
    Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z
    Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex.
    McCoy MA; Senior MM; Gesell JJ; Ramanathan L; Wyss DF
    J Mol Biol; 2001 Feb; 305(5):1099-110. PubMed ID: 11162117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
    Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
    Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
    Ingallinella P; Altamura S; Bianchi E; Taliani M; Ingenito R; Cortese R; De Francesco R; Steinkühler C; Pessi A
    Biochemistry; 1998 Jun; 37(25):8906-14. PubMed ID: 9636032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junction.
    Leinbach SS; Bhat RA; Xia SM; Hum WT; Stauffer B; Davis AR; Hung PP; Mizutani S
    Virology; 1994 Oct; 204(1):163-9. PubMed ID: 8091650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
    Chanprapaph S; Saparpakorn P; Sangma C; Niyomrattanakit P; Hannongbua S; Angsuthanasombat C; Katzenmeier G
    Biochem Biophys Res Commun; 2005 May; 330(4):1237-46. PubMed ID: 15823576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides.
    Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B
    Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redesigning the substrate specificity of the hepatitis C virus NS3 protease.
    Failla CM; Pizzi E; De Francesco R; Tramontano A
    Fold Des; 1996; 1(1):35-42. PubMed ID: 9079362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex formation between the hepatitis C virus serine protease and a synthetic NS4A cofactor peptide.
    Bianchi E; Urbani A; Biasiol G; Brunetti M; Pessi A; De Francesco R; Steinkühler C
    Biochemistry; 1997 Jun; 36(25):7890-7. PubMed ID: 9201934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the substrate specificity of the dengue virus type 2 NS3 serine protease by using internally quenched fluorescent peptides.
    Niyomrattanakit P; Yahorava S; Mutule I; Mutulis F; Petrovska R; Prusis P; Katzenmeier G; Wikberg JE
    Biochem J; 2006 Jul; 397(1):203-11. PubMed ID: 16489931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.
    Butkiewicz N; Yao N; Zhong W; Wright-Minogue J; Ingravallo P; Zhang R; Durkin J; Standring DN; Baroudy BM; Sangar DV; Lemon SM; Lau JY; Hong Z
    J Virol; 2000 May; 74(9):4291-301. PubMed ID: 10756044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.